The Influence of Dopamine Activity on Neuromuscular Function During Passive Heat Stress
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Brock University
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- Wrist flexion torque
Study Overview
Brief Summary
our goal is to study the effects of dopamine activity, using Ritalin ingestion, on neuromuscular function over the course of a progressive heating and cooling protocol developed in our lab. We hypothesize that Ritalin will minimize the previously reported progressive impairment in neuromuscular function with hyperthermia compared to placebo, suggesting that dopamine activity preserves neuromuscular capacity with hyperthermia.
Detailed Description
Increased core temperature (hyperthermia) has been associated with impaired neuromuscular performance, with the majority of research suggesting that the observed fatigue is related to the central nervous system. Small doses of Ritalin has been used to study how changes in dopamine activity affects exercise capacity in the heat. This study found that 20 mg of Ritalin had no effect on exercise capacity in a thermoneutral environment of 18°C. However, when in a hot (30°C) environment, the Ritalin resulted in a 16% improvement in finishing time compared to the placebo trial. Interestingly, the higher output during the Ritalin-hot condition also resulted in higher rates of heat production and a higher (~0.6°C) core temperature, suggesting that dopamine enabled greater voluntary tolerance of hyperthermia. This matches recent work from our own work showing that motivational skills training increased both exercise tolerance and final core temperature, and it is possible that dopamine activity played a role in this improvement.
Ultimately, fatigue is shown in an inability to sustain muscular force. However, the role of dopamine activity on neuromuscular function (e.g., central activation and recruitment of muscle) during hyperthermia is unknown. One study reported that 20 mg of Ritalin did not alter neuromuscular function, but this study was done without thermal stress.
Therefore, our goal is to study the effects of dopamine activity, using Ritalin ingestion, on neuromuscular function over the course of a progressive heating and cooling protocol developed in our lab. We hypothesize that Ritalin will minimize the previously reported progressive impairment in neuromuscular function with hyperthermia (5, 7) compared to placebo, suggesting that dopamine activity preserves neuromuscular capacity with hyperthermia.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Basic Science
- Masking
- Single (Investigator)
Masking Description
Double-blinding of participant and investigator, with independent investigator in charge of placebo and drug.
Eligibility Criteria
- Ages
- 18 Years to 30 Years (Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •High aerobic fitness (>55 mL/kg/min maximal aerobic capacity)
Exclusion Criteria
- •diagnosed cardiovascular, respiratory and/or neuromuscular disease, prescription of Ritalin or any drugs for hyperactivity within the past 1 year, any current prescription medication (except for asthma/allergy inhalers), any contraindications to Ritalin.
Arms & Interventions
Ritalin
20 mg Ritalin, 90 min before testing
Intervention: Ritalin 20 mg Tablet (Drug)
Control
Identical size/taste placebo pill, 90 min before testing
Intervention: Placebo Oral Tablet (Drug)
Outcomes
Primary Outcomes
Wrist flexion torque
Time Frame: 2-4 hours after ingestion
Maximal voluntary contraction of wrist flexion
Secondary Outcomes
No secondary outcomes reported
Investigators
Stephen Cheung
Professor
Brock University
